Back

Duloxetine Alvogen Gastro-Resistant Capsules 30mg and 60mg

Duloxetine Hydrochloride

Treatment of major depressive disorder, diabetic peripheral neuropathic pain and generalised anxiety disorder. DULOXETINE ALVOGEN is indicated in adults.

Major depressive disorder

The starting and recommended maintenance dose is 60 mg once daily with or without food. Doses above 60 mg once daily, up to a maximum dose of 120 mg per day have been evaluated from a safety perspective in clinical trials.

 

Generalised anxiety disorder

The recommended starting dose in patients with generalised anxiety disorder is 30 mg once daily with or without food. In patients with insufficient response the dose should be increased to 60 mg, which is the usual maintenance dose in most patients. In patients with co-morbid major depressive disorder, the starting and maintenance dose is 60 mg once daily.

Doses up to 120 mg per day have been shown to be efficacious and have been evaluated from a safety perspective in clinical trials. In patients with insufficient response to 60 mg, escalation up to 90 mg or 120 mg may therefore be considered. Dose escalation should be based upon clinical response and tolerability.

 

Diabetic peripheral neuropathic pain

The starting and recommended maintenance dose is 60 mg daily with or without food. Doses above 60 mg once daily, up to a maximum dose of 120 mg per day administered in evenly divided doses, have been evaluated from a safety perspective in clinical trials.

30mg x 30’s, 60mg x 30’s

30mg       HK-64887

60mg       HK-64886

Duloxetine Hydrochloride